Shopping Cart
- Remove All
- Your shopping cart is currently empty
MS023 trihydrochloride (MS023 3HCl) is a selective and potent human type I protein arginine methyltransferase (PRMT) inhibitor with potential anticancer activity against PRMT1, PRMT3, PRMT4, PRMT6, and PRMT8 for cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $143 | 35 days | |
5 mg | $623 | 35 days | |
10 mg | $1,090 | 35 days | |
25 mg | $2,390 | 35 days |
Description | MS023 trihydrochloride (MS023 3HCl) is a selective and potent human type I protein arginine methyltransferase (PRMT) inhibitor with potential anticancer activity against PRMT1, PRMT3, PRMT4, PRMT6, and PRMT8 for cancer research. |
Targets&IC50 | PRMT8:5 nM, PRMT4:83 nM, PRMT1:30 nM, PRMT6:4 nM, PRMT3:119 nM |
In vitro | MS023 trihydrochloride (1-1000 nM; 48 hours) inhibits the activity of PRMT1 methyltransferase in MCF7 cells[2]. MS023 trihydrochloride (1-1000 nM; 20 hours) inhibits the activity of PRMT6 methyltransferase in HEK293 cells[2].' |
In vivo | Combination administration of MS023 trihydrochloride (160 mg/kg, ip) and PKC412 (100 mg/kg, ig) disrupts the propagation of MLL-r Acute Lymphoblastic Leukemia (ALL) by inhibiting the maintenance of functional MLL-r ALL initiating cells[1]. |
Alias | MS023 3HCl |
Molecular Weight | 396.78 |
Formula | C17H28Cl3N3O |
Cas No. | 2108631-19-0 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.